基本属性 生物活性靶点体外研究体内研究 用途与合成方法 OSU-T315 价格(试剂级) 供应商 供应信息

OSU-T315

OSU-T315

中文名称:OSU-T315
英文名称:ILK-IN-2
CAS号:2070015-22-2
分子式:C30H30F3N5O
分子量:533.59
EINECS号:
Mol文件:2070015-22-2.mol
OSU-T315 结构式

OSU-T315 性质

储存条件 2-8°C(protect from light)
溶解度 DMSO:≥50mg/mL(93.70mM);水:< 0.1 mg/mL(不溶)
形态 固体
颜色 白色至米白色

OSU-T315 用途与合成方法

OSU-T315 (ILK-IN-2)是一种有效的 Integrin-Linked Kinase (ILK) 的抑制剂,其IC50值为0.6 μM。OSU-T315 可诱导自噬和细胞凋亡,这两者都是其抗增殖活性不可或缺的。OSU-T315 具有抗肿瘤活性。
TargetValue
ILK
(Cell-free assay)
0.6 μM

OSU-T315 (Compound 22; 0-5 μM; 24 hours) exhibits high in vitro potency against a panel of prostate and breast cancer cell lines with a IC 50 range of 1-2.5 μM.
OSU-T315 (0-2.5 μM; 24 hours) can reduce YB-1, HER2, and EGFR expression; shows a modest suppressive effect on phosphorylated S6 levels, exhibits dose-dependent suppressive effects on the levels of phospho-ERK1/2 and phospho-p38, while that of phospho-JNK remains unaltered in PC-3 cell.
OSU-T315 (0-4 μM; 24 hours) causes autophagy through ILK inhibition.

Western Blot Analysis

Cell Line: PC-3 cells; MDA-MB-231 cells
Concentration: 1 μM, 2 μM, 3 μM, 4 μM; 0.5 μM, 1 μM, 1.5 μM, 2 μM, 2.5 μM
Incubation Time: 24 hours
Result: Exhibited a dose-dependent decreasing effect on the phosphorylation of pS6, ERKs, and p38 in PC-3 cells and MDA-MB-231 cells.

Cell Viability Assay

Cell Line: Prostate cancer cells: LNCaP, PC-3; breast cancer cells: MDA-MB-231, MDA-MB-468, SKBR3, MCF-7; PrEC and MEC cells
Concentration: 0-5 μM
Incubation Time: 24 hours
Result: Suppressed cancer cells viability in breast and prostate cancer cells (IC (50), 1-2.5μM).

Apoptosis Analysis

Cell Line: PC-3 cells
Concentration: 1 μM, 2 μM, 3 μM, 4 μM
Incubation Time: 24 hours
Result: Induced accumulation of LC3-II and PARP cleavage.

OSU-T315 (Oral gavage; 25 mg/kg, 50 mg/kg; single daily; 35 days) has a suppressive effect of on PC-3 xenograft tumor growth .
No other obvious toxicity is observed in mice.

Animal Model: Male NCr athymic nude mice with PC-3 tumor xenografts
Dosage: 25 mg/kg; 50 mg/kg
Administration: Oral gavage; single daily; 35 days
Result: Resulted in suppression of tumor growth relative to the vehicle control after 35 days of treatment (48% and 62% suppression for 25 and 50 mg/kg, respectively).

OSU-T315 价格(试剂级)

更新日期 产品编号 产品名称 CAS号 包装 价格
2024-11-08 HY-18676B OSU-T315 2070015-22-2 2mg 1200
2024-11-08 HY-18676B OSU-T315 2070015-22-2 5mg 2400

OSU-T315供应商 更多

晶墨(厦门)生物科技有限公司
现货
联系电话: 13621943973
产品介绍:
英文名称:ILK-IN-2
CAS:2070015-22-2
纯度:>98%
备注:2g
库存量:2g
现货日期:2024/11/25 8:44:32
四川省维克奇生物科技有限公司
联系电话:028-81700200 18116577057
产品介绍:
英文名称:OSU-T315
CAS:2070015-22-2
纯度:HPLC≥98%
包装信息:20mg/10
上海一飞生物科技有限公司
联系电话:021-65675885 18964387627
产品介绍:
英文名称:OSU-T315
CAS:2070015-22-2
纯度:98.00%
包装信息:1mg;2mg;5mg
备注:试剂级
上海超岚化工科技中心
联系电话:021-QQ:65489617 15618227136
产品介绍:
英文名称:ILK-IN-2
CAS:2070015-22-2
纯度:98%
包装信息:5MG;10MG;50MG;100MG,1G,5G,100G
北京普西唐生物科技有限公司
联系电话:010-60605840 18892239720
产品介绍:
英文名称:OSU-T315
CAS:2070015-22-2
纯度:98%
包装信息:10mg;50mg

最新发布供应信息

OSU-T315
四川省维克奇生物科技有限公司 2024-11-21
化合物 ILK-IN-2|T5485|TargetMol
TargetMol中国(陶术生物) 2024-09-30